Elanco Animal Health Inc (ELAN) | |||
---|---|---|---|
19.91 0.47 (2.42%) | 08-08 16:00 | ||
Open: | 19.59 | Pre. Close: | 19.44 |
High: | 20.46 | Low: | 19.3 |
Volume: | 10,571,382 | Market Cap: | 9,439M |
Prices Prediction (Update @5:00pm) | ||
---|---|---|
If tomorrow: | Open lower | Open higher |
High: | 20.495 - 20.593 | 20.593 - 20.682 |
Low: | 19.065 - 19.176 | 19.176 - 19.277 |
Close: | 19.725 - 19.91 | 19.91 - 20.077 |
Stock Technical Analysis | |
---|---|
Overall: | ![]() ![]() ![]() |
Target: | Six months: 24.49 ![]() One year: 28.61 ![]() |
Support: | Support1: 19.53 ![]() Support2: 18.64 ![]() |
Resistance: | Resistance1: 20.97 ![]() Resistance2: 24.49 ![]() |
Pivot: | 20.10 ![]() |
Moving Averages: | MA(5): 19.42 ![]() MA(20): 20.04 ![]() MA(100): 23.00 ![]() MA(250): 27.10 ![]() |
MACD: | MACD(12,26): -0.36 ![]() Signal(12,26,9): -0.34 ![]() |
%K %D: | %K(14,3): 32.43 ![]() %D(3): 20.39 ![]() |
RSI: | RSI(14): 45.86 ![]() |
52-Week: | High: 35 Low: 18.64 Change(%): -36.9 |
Average Vol(K): | 3-Month: 4543 10-Days: 6075 |
Price, MAs and Bollinger Bands |
---|
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ ELAN ] has closed above bottom band by 41.7%. Bollinger Bands are 23.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
Stock chart |
---|
![]() |
Financial Analysis | |
---|---|
Price to Book Value: | Outperform |
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. | |
Price to Earnings: | Underperform |
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). | |
Discounted cash flow: | Outperform |
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. | |
Return on Assets: | Neutral |
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. | |
Return on Equity: | Neutral |
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. | |
Debt to Equity: | Outperform |
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Stock Basics & Statistics | |
---|---|
Exchange: New York Stock Exchange | |
Sector: Healthcare | |
Industry: Drug Manufacturers—Specialty & Generic | |
Shares Out. (M) | 474.10 |
Shares Float (M) | 426.08 |
% Held by Insiders | 4.13 |
% Held by Institutions | 106.60 |
Shares Short (K) | 14740 |
Shares Short Prior Month (K) | 17550 |
Stock Financials | |
---|---|
EPS | -0.750 |
Book Value (p.s.) | 16.060 |
Profit Margin | -7.64 |
Operating Margin | 9.75 |
Return on Assets (ttm) | 1.7 |
Return on Equity (ttm) | -4.7 |
Qtrly Rev. Growth | -1.4 |
Gross Profit (p.s.) | 5.674 |
Sales Per Share | 10.019 |
EBITDA (p.s.) | 2.320 |
Qtrly Earnings Growth | |
Operating Cash Flow (M) | 399.00 |
Levered Free Cash Flow (M) | 539.50 |
Stock Valuation | |
---|---|
PE Ratio | -26.55 |
PEG Ratio | 1.32 |
Price to Book value | 1.24 |
Price to Sales | 1.99 |
Price to Cash Flow | 23.66 |
Stock Dividends | |
---|---|
Dividend | |
Dividend Yield | |
Dividend Growth |